ReviewTaiwan journal of ophthalmology
Presbyopia intraocular lens in aberrated corneas.
Review in Taiwan journal of ophthalmology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Therapeutic Value and Optical Performance of Small-Aperture Intraocular Implants: A Systematic Review.Annals of biomedical engineering · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Increasingly, patients desire spectacle independence postcataract surgery, for which multifocal intraocular lens (IOL) implantation is widely performed. However, multifocal IOLs have certain drawbacks: fixed focal change, increased photic phenomena, and unsuitability for use in aberrated eyes. Monovision is an option, but can only achieve fixed focal points as well. An alternative IOL that bridges the gap between providing an extended depth of focus (DOF) and decreasing induced aberrations is the IC-8 Apthera IOL, which utilizes small aperture technology to provide a continuous DOF with good near, intermediate and distance vision in eyes with up to 1.50D of preoperative astigmatism. Importantly, the IC-8 IOL has shown potential for use in aberrated eyes, demonstrating increased visual acuity at all distances, good contrast sensitivity, minimal photic phenomena, and high levels of spectacle independence in patients with corneal irregularities and higher order aberrations, especially postrefractive surgery. The IC-8 IOL has also been able to achieve good centration and positional stability, which is key for good visual outcomes and spectacle independence after surgery. This paper aims to bring together relevant literature to review the outcomes of IC-8 IOL.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.